The U.S. Drug Enforcement Administration (DEA) has delayed the scheduled December 2 hearing for expert testimony on federal cannabis rescheduling until January or February 2025.
OG Article: here
View our Fair Use Policy: here
Chief Administrative Law Judge John Mulrooney postponed the hearing, citing a need for more detailed background information on the over two dozen experts approved by DEA Administrator Anne Milgram earlier in the week.
Judge Mulrooney noted that the participant list provided only email addresses, lacking detailed notices of appearance, addresses, or phone numbers, as required for such proceedings.
While the December 2 hearing will still proceed, it will do so without expert testimony. This delay raises concerns among cannabis advocates about the potential impact on the Biden Administration's rescheduling timeline, especially since the hearing now appears likely to occur after the presidential election.
This rescheduling effort has drawn political attention. Democratic presidential nominee Vice President Kamala Harris recently stated her intent to pursue full federal cannabis legalization if elected, a step beyond the current administration's rescheduling approach. Former President Donald Trump, the Republican nominee, has expressed support for rescheduling but has not explicitly endorsed federal legalization, though he has stated he would support the Florida ballot measure to legalize cannabis.
Comments